Byrne Asset Management’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
51,250
+36,550
+249% +$129K 0.09% 179
2026
Q1
$57.9K Hold
14,700
0.03% 269
2025
Q4
$116K Buy
+14,700
New +$118K 0.06% 202

Other funds holding CRVO

Byrne Asset Management's CRVO Position: Q2 2026 in Review

Byrne Asset Management increased its CervoMed (CRVO) stake by 249% in Q2 2026, buying an estimated $129K and bringing the position to 51,250 shares worth $159K. The position accounts for 0.09% of the portfolio, ranked #179.

Byrne Asset Management first reported a position in CRVO in Q4 2025 and has held it in 3 quarters since. 2 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Byrne Asset Management held 51,250 shares of CervoMed worth $159K as of Q2 2026.
  • Byrne Asset Management bought 36,550 CervoMed shares in Q2 2026, an estimated $129K.
  • CervoMed made up 0.09% of Byrne Asset Management's portfolio in Q2 2026, its #179 holding.
  • Byrne Asset Management first reported a position in CervoMed in Q4 2025 and has held it in 3 quarters since.
  • 2 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.